Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cognitive and motor function enhanced by ASKT-4290 in aged mice

July 18, 2019

Cyclerion Therapeutics synthesizes sGC activators

July 18, 2019

Researchers test intranasal dantrolene for the treatment of Alzheimer's disease

July 18, 2019

Intracutaneous zolmitriptan given high Migraine-ACT scores in clinical trial

July 18, 2019

Anti-SEMA4D antibody VX-15 may offer therapeutic potential for Alzheimer's disease

July 18, 2019

Tipepidine shows promise as a supplementary medication in children with ADHD

July 18, 2019

Microglia and AD

July 18, 2019

Researchers in search of small-molecule NAMPT activators for Alzheimer's disease

July 17, 2019

Mallinckrodt discontinues phase IIb study of Acthar gel in ALS

July 17, 2019

MDA funding supports development of small-molecule drugs to increase sarcospan expression for DMD

July 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...